Developing a Gene Therapy for HD.mp4 from Justin Aubin on Vimeo.

Company Description:

Voyager Therapeutics is a Cambridge, MA based AAV gene therapy company focused on developing and delivering life-changing therapies to people living with severe neurological diseases, including Huntington’s Disease. We are planning to initiate VYTAL, a phase 1 clinical trial studying our single-dose gene therapy, by the end of 2021. Please contact us at for more information.

Learn more:

Gene Therapy From AA to V

VYTAL Patient Brochure

Voyager Approach to Gene Therapy

Understanding Clinical Trial


Visit our Website